Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 901 AL 915

N-glycan and Alzheimer's disease

Kizuka Y, Kitazume S, Taniguchi N.

Biochim Biophys Acta Gen Subj. 2017 Oct;1861(10):2447-2454. doi: 10.1016/j.bbagen.2017.04.012. Epub 2017 Apr 29.

Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials

Nelson TJ, Sun MK, Lim C, Sen A, Khan T, Chirila FV, Alkon DL.

J Alzheimers Dis. 2017;58(2):521-535. doi: 10.3233/JAD-170161.

Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis

Duke Han S, Nguyen CP, Stricker NH, Nation DA.

Neuropsychol Rev. 2017 Dec;27(4):305-325. doi: 10.1007/s11065-017-9345-5. Epub 2017 May 11.

Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1

Tort-Merino A, Valech N, Peñaloza C, Grönholm-Nyman P, León M, Olives J, Estanga A, Ecay-Torres M, Fortea J, Martínez-Lage P, Molinuevo JL, Laine M, Rodríguez-Fornells A, Rami L.

J Alzheimers Dis. 2017;58(3):855-870. doi: 10.3233/JAD-161173.

Evolving Relevance of Neuroproteomics in Alzheimer's Disease

Lista S, Zetterberg H, O'Bryant SE, Blennow K, Hampel H.

Methods Mol Biol. 2017;1598:101-115. doi: 10.1007/978-1-4939-6952-4_5.

Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease

Lista S, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Floris R, Garaci F, Hampel H; Alzheimer Precision Medicine Initiative (APMI).

Neurochem Int. 2017 Sep;108:355-360. doi: 10.1016/j.neuint.2017.05.010. Epub 2017 May 17.

Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report

Wallin A, Kapaki E, Boban M, Engelborghs S, Hermann DM, Huisa B, Jonsson M, Kramberger MG, Lossi L, Malojcic B, Mehrabian S, Merighi A, Mukaetova-Ladinska EB, Paraskevas GP, Popescu BO, Ravid R, Traykov L, Tsivgoulis G, Weinstein G, Korczyn A, Bjerke M, Rosenberg G.

BMC Neurol. 2017 May 23;17(1):102. doi: 10.1186/s12883-017-0877-3.

Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study

Chen SH, Bu XL, Jin WS, Shen LL, Wang J, Zhuang ZQ, Zhang T, Zeng F, Yao XQ, Zhou HD, Wang YJ.

Medicine (Baltimore). 2017 May;96(21):e6843. doi: 10.1097/MD.0000000000006843.

Peripheral Inflammatory Biomarkers and Cognitive Decline in Older Adults With and Without Alzheimer's Disease: A Systematic Review

Li D, Yu F.

J Gerontol Nurs. 2017 Dec 1;43(12):53-60. doi: 10.3928/00989134-20170519-01. Epub 2017 May 31.

[Melatonin as a molecular marker of age-related pathologies]

Zuev VA, Trifonov NI, Linkova NS, Kvetnaia TV.

Adv Gerontol. 2017;30(1):62-69.

PET Imaging for Early Detection of Alzheimer's Disease: From Pathologic to Physiologic Biomarkers

Bao W, Jia H, Finnema S, Cai Z, Carson RE, Huang YH.

PET Clin. 2017 Jul;12(3):329-350. doi: 10.1016/j.cpet.2017.03.001. Epub 2017 May 2.

Plasma REST: a novel candidate biomarker of Alzheimer's disease is modified by psychological intervention in an at-risk population

Ashton NJ, Hye A, Leckey CA, Jones AR, Gardner A, Elliott C, Wetherell JL, Lenze EJ, Killick R, Marchant NL.

Transl Psychiatry. 2017 Jun 6;7(6):e1148. doi: 10.1038/tp.2017.113.

The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials

Olsson B, Schott JM, Blennow K, Zetterberg H.

Expert Rev Neurother. 2017 Aug;17(8):767-775. doi: 10.1080/14737175.2017.1341311. Epub 2017 Jun 19.

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

Donohue MC, Sperling RA, Petersen R, Sun CK, Weiner MW, Aisen PS; Alzheimer’s Disease Neuroimaging Initiative.

JAMA. 2017 Jun 13;317(22):2305-2316. doi: 10.1001/jama.2017.6669.

Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products

Yi L, Liu W, Wang Z, Ren D, Peng W.

Ann N Y Acad Sci. 2017 Jun;1398(1):130-141. doi: 10.1111/nyas.13385. Epub 2017 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias